Characterization of multiple sclerosis lesions with distinct clinical correlates through quantitative diffusion MRI.


Journal

NeuroImage. Clinical
ISSN: 2213-1582
Titre abrégé: Neuroimage Clin
Pays: Netherlands
ID NLM: 101597070

Informations de publication

Date de publication:
2020
Historique:
received: 22 06 2020
revised: 24 08 2020
accepted: 01 09 2020
pubmed: 21 9 2020
medline: 29 6 2021
entrez: 20 9 2020
Statut: ppublish

Résumé

Diffusion magnetic resonance imaging can reveal quantitative information about the tissue changes in multiple sclerosis. The recently developed multi-compartment spherical mean technique can map different microscopic properties based only on local diffusion signals, and it may provide specific information on the underlying microstructural modifications that arise in multiple sclerosis. Given that the lesions in multiple sclerosis may reflect different degrees of damage, we hypothesized that quantitative diffusion maps may help characterize the severity of lesions "in vivo" and correlate these to an individual's clinical profile. We evaluated this in a cohort of 59 multiple sclerosis patients (62% female, mean age 44.7 years), for whom demographic and disease information was obtained, and who underwent a comprehensive physical and cognitive evaluation. The magnetic resonance imaging protocol included conventional sequences to define focal lesions, and multi-shell diffusion imaging was used with b-values of 1000, 2000 and 3000 s/mm

Identifiants

pubmed: 32950904
pii: S2213-1582(20)30248-5
doi: 10.1016/j.nicl.2020.102411
pmc: PMC7502564
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

102411

Subventions

Organisme : Medical Research Council
ID : MR/K501256/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N013468/1
Pays : United Kingdom

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Références

Mult Scler. 2006 Apr;12(2):187-95
pubmed: 16629422
Neuroimage. 2018 Nov 15;182:8-38
pubmed: 29793061
J Neuropathol Exp Neurol. 2006 Apr;65(4):305-18
pubmed: 16691112
Neuroimage. 2017 Nov 1;161:149-170
pubmed: 28826946
Radiology. 2011 Jun;259(3):659-81
pubmed: 21602503
J Magn Reson B. 1994 Mar;103(3):247-54
pubmed: 8019776
Ann Neurol. 2000 Jun;47(6):707-17
pubmed: 10852536
Neuroimage. 2018 Apr 15;170:174-181
pubmed: 28315460
Front Neurol. 2017 Sep 04;8:433
pubmed: 28928705
Curr Opin Neurol. 2002 Jun;15(3):239-45
pubmed: 12045719
NMR Biomed. 2010 Aug;23(7):865-72
pubmed: 20882528
Neuroimage. 2017 Aug 15;157:561-574
pubmed: 28602815
Neuroimage. 2014 May 15;92:381-97
pubmed: 24530839
Eur J Neurol. 2010 Dec;17(12):1471-5
pubmed: 20500805
AJNR Am J Neuroradiol. 2020 May;41(5):751-757
pubmed: 32354707
Ann Neurol. 2011 Feb;69(2):292-302
pubmed: 21387374
Lancet Neurol. 2015 Mar;14(3):302-17
pubmed: 25662900
Neurology. 1983 Nov;33(11):1444-52
pubmed: 6685237
Magn Reson Med. 2016 Apr;75(4):1752-63
pubmed: 25974332
Ann Clin Transl Neurol. 2019 Sep;6(9):1595-1605
pubmed: 31407532
Neuroimage. 2019 Nov 15;202:116137
pubmed: 31473352
Magn Reson Med. 2005 Jun;53(6):1432-40
pubmed: 15906300
AJNR Am J Neuroradiol. 2019 Nov;40(11):1871-1877
pubmed: 31694819
Neurology. 1998 May;50(5):1282-8
pubmed: 9595975
Magn Reson Med. 2004 Nov;52(5):1052-9
pubmed: 15508157
NMR Biomed. 2018 Apr;31(4):e3894
pubmed: 29388719
Neurology. 2005 Apr 12;64(7):1144-51
pubmed: 15824338
Neuroimage. 2005 Feb 15;24(4):1139-46
pubmed: 15670691
Neurology. 1991 May;41(5):685-91
pubmed: 2027484
Neuroimage. 2009 Oct 15;48(1):63-72
pubmed: 19573611
Neuroimage Clin. 2018 Jul 12;20:161-168
pubmed: 30094165
Mult Scler. 2009 Oct;15(10):1164-74
pubmed: 19667010
Brain Pathol. 2007 Apr;17(2):210-8
pubmed: 17388952
Mult Scler. 2014 Feb;20(2):214-9
pubmed: 23877971
NMR Biomed. 2019 Apr;32(4):e3998
pubmed: 30321478
Neurology. 2001 Feb 13;56(3):304-11
pubmed: 11171893
JAMA Neurol. 2019 Dec 1;76(12):1474-1483
pubmed: 31403674
Neuroimage. 2008 Oct 1;42(4):1366-80
pubmed: 18603006
Brain. 2019 Jul 1;142(7):1858-1875
pubmed: 31209474
NMR Biomed. 2002 Nov-Dec;15(7-8):435-55
pubmed: 12489094

Auteurs

Eloy Martínez-Heras (E)

Center of Neuroimmunology, Laboratory of Advanced Imaging in Neuroimmunological Diseases, Hospital Clinic Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and Universitat de Barcelona, Barcelona, Spain.

Elisabeth Solana (E)

Center of Neuroimmunology, Laboratory of Advanced Imaging in Neuroimmunological Diseases, Hospital Clinic Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and Universitat de Barcelona, Barcelona, Spain.

Ferran Prados (F)

E-health Centre, Universitat Oberta de Catalunya, Barcelona, Spain; Centre for Medical Image Computing (CMIC), Department of Medical Physics and Bioengineering, University College London, London, UK; NMR Research Unit, Queen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, University College London, London, UK.

Magí Andorrà (M)

Center of Neuroimmunology, Laboratory of Advanced Imaging in Neuroimmunological Diseases, Hospital Clinic Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and Universitat de Barcelona, Barcelona, Spain.

Aleix Solanes (A)

Imaging of Mood- and Anxiety-related Disorders (IMARD) Group, IDIBAPS and CIBERSAM, Barcelona, Spain.

Elisabet López-Soley (E)

Center of Neuroimmunology, Laboratory of Advanced Imaging in Neuroimmunological Diseases, Hospital Clinic Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and Universitat de Barcelona, Barcelona, Spain.

Carmen Montejo (C)

Center of Neuroimmunology, Laboratory of Advanced Imaging in Neuroimmunological Diseases, Hospital Clinic Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and Universitat de Barcelona, Barcelona, Spain.

Irene Pulido-Valdeolivas (I)

Center of Neuroimmunology, Laboratory of Advanced Imaging in Neuroimmunological Diseases, Hospital Clinic Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and Universitat de Barcelona, Barcelona, Spain.

Salut Alba-Arbalat (S)

Center of Neuroimmunology, Laboratory of Advanced Imaging in Neuroimmunological Diseases, Hospital Clinic Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and Universitat de Barcelona, Barcelona, Spain.

Nuria Sola-Valls (N)

Center of Neuroimmunology, Laboratory of Advanced Imaging in Neuroimmunological Diseases, Hospital Clinic Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and Universitat de Barcelona, Barcelona, Spain.

Maria Sepúlveda (M)

Center of Neuroimmunology, Laboratory of Advanced Imaging in Neuroimmunological Diseases, Hospital Clinic Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and Universitat de Barcelona, Barcelona, Spain.

Yolanda Blanco (Y)

Center of Neuroimmunology, Laboratory of Advanced Imaging in Neuroimmunological Diseases, Hospital Clinic Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and Universitat de Barcelona, Barcelona, Spain.

Albert Saiz (A)

Center of Neuroimmunology, Laboratory of Advanced Imaging in Neuroimmunological Diseases, Hospital Clinic Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and Universitat de Barcelona, Barcelona, Spain.

Joaquim Radua (J)

Imaging of Mood- and Anxiety-related Disorders (IMARD) Group, IDIBAPS and CIBERSAM, Barcelona, Spain; Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; Early Psychosis: Interventions and Clinical-detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK. Electronic address: radua@clinic.cat.

Sara Llufriu (S)

Center of Neuroimmunology, Laboratory of Advanced Imaging in Neuroimmunological Diseases, Hospital Clinic Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and Universitat de Barcelona, Barcelona, Spain. Electronic address: sllufriu@clinic.cat.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH